SCM
ZBH icon

SeaStone Capital Management’s Zimmer Biomet ZBH Stock Holding History

SeaStone Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-229,137
Closed -$25.2M – 41
2014
Q4 		$25.2M Buy
229,137
+24,601
+12% +$2.59M 3.92% 10
2014
Q3 		$20M Buy
+204,536
New +$20.1M 2.65% 17

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SeaStone Capital Management's ZBH Position: Q1 2015 in Review

SeaStone Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2015, closing a stake of 229,137 shares — an estimated $25.2M sold.

SeaStone Capital Management first reported a position in ZBH in Q3 2014 and held it in 2 quarters. The position peaked at $25.2M in Q4 2014. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

  • SeaStone Capital Management reported no remaining Zimmer Biomet position as of Q1 2015 after selling out during the quarter.
  • SeaStone Capital Management sold 229,137 Zimmer Biomet shares in Q1 2015, an estimated $25.2M.
  • SeaStone Capital Management first reported a position in Zimmer Biomet in Q3 2014 and held it in 2 quarters.
  • SeaStone Capital Management's Zimmer Biomet position peaked at $25.2M in Q4 2014.
  • 762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on SeaStone Capital Management's 13F filing for Q1 2015, filed 15 May 2015.